peripartum cardiomyopathy ppcm form dilated cardiomyopathy defined deterioration cardiac function presenting typically last month pregnancy six months postpartum forms dilated cardiomyopathy ppcm involves systolic dysfunction heart decrease left ventricular ejection fraction ef associated congestive heart failure increased risk atrial ventricular arrhythmias thromboembolism blockage blood vessel blood clot even sudden cardiac death essence heart muscle contract forcefully enough pump adequate amounts blood needs bodys vital ppcm diagnosis exclusion wherein patients prior history heart disease known possible causes heart failure echocardiogram used diagnose monitor effectiveness treatment cause ppcm unknown currently researchers investigating cardiotropic viruses autoimmunity immune system dysfunction toxins serve triggers immune system dysfunction micronutrient trace mineral deficiencies genetics possible components contribute cause development ppcm relation eclampsia hypertension process ppcm begins unknown trigger possibly cardiotropic virus yet unidentified catalyst initiates inflammatory process heart consequently heart muscle cells damaged die become scar tissue scar tissue ability contract therefore effectiveness pumping action heart decreased also damage cytoskeletal framework heart causes heart enlarge stretch alter shape also decreasing hearts systolic function output initial inflammatory process appears cause autoimmune immune dysfunctional process turn fuels initial inflammatory process progressive loss heart muscle cells leads eventual heart increased research toxic hormonal environment generates late pregnancy contributor development ppcm prolactin levels increase late pregnancy weeks following birth kilodalton nterminal fragment prolactin hormone implicated causal role genetically susceptible individuals thus therapeutic interventions block prolactin pathway prevent generation fragment investigated potential treatments stop disease progression special considerations made delivery ppcm diagnosis made birth multidisciplinary team assembled including experts obstetrics cardiology maternal fetal medicine anesthesiology stable patients delivered vaginally unless obstetric reasons cesarean section attempts stabilize mother delay birth minimize potential complications premature birth reasonable strategy following delivery due increase venous return patients need closely monitored fluid overload pulmonary symptoms usually include one following orthopnea difficulty breathing lying flat dyspnea shortness breath exertion pitting edema swelling cough frequent nighttime urination excessive weight gain last month pregnancy kgweek two four pounds per week palpitations sensation racing heartrate skipping beats long pauses beats fluttering chest pain tightness fatigue shortness breath often described ppcm patients inability take deep full breath get enough air lungs also patients often describe need prop overnight using two pillows order breathe better symptoms swelling andor cough may indications pulmonary edema fluid lungs resulting acute heart failure ppcmcitation needed physical examination may reveal jugular venous distention displaced apical impulse third heart sound murmur consistent mitral regurgitation tachypnea tachycardia pulmonary rales peripheral diagnosis may delayed dismissed early symptoms may interpreted typical normal pregnancy delays diagnosis treatment ppcm associated increased morbidity also quite common women present evidence embolus clot passing heart vital organ causing complications stroke loss circulation limb even coronary artery occlusion blockage typical myocardial infarction heart reasons paramount clinicians hold high suspicion ppcm peri postpartum patient unusual unexplained symptoms presentations following screening tool may useful patients medical professionals determining need take action diagnose initial evaluation include blood work ppcm diagnosis exclusion meaning conditions need evaluated ruled diagnosis used anemia electrolyte abnormalities thyroid dysfunction renal liver dysfunction need ruled testing also include chest xray brain natriuretic peptide levels ekg echocardiogram cardiac mri cardiac catheterization specific test get diagnosis ultrasound peripartum ultrasound peripartum ultrasound peripartum early detection treatment associated higher rates recovery decreased morbidity treatment ppcm similar treatment congestive heart failure conventional heart failure treatment includes use diuretics beta blockers bb angiotensinconverting enzyme inhibitors acei delivery diuretics preferably furosemide help body get rid excess water weight also lower blood pressure fluid restriction also used help limit excess water body using diuretics pregnancy needs done carefully diuretics impair blood flow placenta could potentially cause harm fetus hydrochlorothiazide furosemide safe pregnancy acei bb improve blood circulation contribute reversal immune system dysfunction associated ppcm acei well tolerated patient replaced angiotensin receptor blockers arb acei arbs contraindicated pregnancy breastfeeding used postpartum period long breastfeeding hydralazine nitrates may replace acei breastfeeding mothers delivery however evidence suggests course treatment may effective acei beneficial ef less anticoagulation indicated greater risk developing left ventricular thrombi blood clots sometimes implantation left ventricular assist device lvad even heart transplant also becomes important patient receives regular followup care including frequent echocardiograms monitor improvement lack thereof particularly changes medical treatment regimes patients respond initial treatment defined left ventricular ef remaining two months three months conventional treatment may merit investigation including cardiac magnetic resonance imaging mri cardiac catheterization endomyocardial biopsy special staining viral polymerase chain reaction pcr analysis antiviral therapy immunoabsorption intravenous gamma globulin immunomodulation therapy may considered accordingly following controlled researchtype since one knows sure exactly discontinue treatment even recovery occurs quickly still recommended acei bb continued least one year considering discontinuing heart failure medications weaned gradually time patients closely monitored ppcm patients increased risk sudden death seen benefit implantable cardioverter defibrillator icd cardiac resynchronization therapy prevent sudden cardiac death however view reversible cardiomyopathy sometimes implantable cardioverterdefibrillator icd cardiac resynchronization therapy crt routinely used reserved severe lv dysfunction high risk bromocriptine studied another potential treatment option due interference prolactin pathway may cause ppcm several studies shown bromocriptine addition standard heart failure medications produce better outcomes terms overall recovery rate recent studies indicate newer conventional heart failure treatment consisting diuretics ace inhibitors beta blockers survival rate high better almost ppcm patients improve united states ppcm patients experience complete recovery heart function ef almost recovered patients eventually able discontinue medications resulting relapse normal life misconception hope recovery depends upon improvement recovery within first six months diagnosis many women continue improve recover even years diagnosis continued medicinal fully recovered subsequent pregnancy possibility relapse recurrence heart failure subsequent pregnancy avoided left ventricular function recovered ef lower however many women fully recovered ppcm gone successful subsequent significant study reports risk recurrence heart failure recovered ppcm patients result subsequent pregnancy approximately chance relapse may even smaller normal contractile reserve demonstrated stress subsequent pregnancy careful monitoring necessary stress test echocardiogram complete prior subsequent pregnancy relapse occurs conventional treatment resumed including hydralazine nitrates plus betablockers pregnancy aceinhibitors plus betablockers following pregnancycitation needed factors associated better prognosis small left ventricle diastolic dimension lvef greater time diagnosis absence troponin elevation absence lv thrombus nonafrican american ethnicity factors indicate poor prognosis qrs greater milliseconds delay diagnosis high nyha class multiparity african mortality estimates significant differences depending racial group studied geographical location length followup study year followup united states mortality rates range estimated incidence ppcm united states live affect women races prevalent countries example estimates suggest ppcm occurs rates one live births south african bantus high one studies assert ppcm may slightly prevalent among older women higher numbers liveborn children among women older younger extremes childbearing however quarter third ppcm patients young women given birth first citations use tocolytic agents development preeclampsia toxemia pregnancy pregnancyinduced hypertension pih may contribute worsening heart failure cause ppcm majority women developed ppcm neither received tocolytics preeclampsia looking occurrence ppcm worldwide incidence ppcm well correlated maternal mortality rates means areas higher maternal mortality also higher rates ppcm suggests level perinatal care may impact incidence short ppcm occur woman racial background age reproductive years httpsenwikipediaorgwikiperipartumcardiomyopathy